1.44
                                            Schlusskurs vom Vortag:
              $1.47
            Offen:
              $1.46
            24-Stunden-Volumen:
                1.64M
            Relative Volume:
              0.65
            Marktkapitalisierung:
                $145.75M
            Einnahmen:
              $100.56M
            Nettoeinkommen (Verlust:
              $-119.05M
            KGV:
              -1.1707
            EPS:
                -1.23
            Netto-Cashflow:
                $-231.16M
            1W Leistung:
              -4.00%
            1M Leistung:
              -56.63%
            6M Leistung:
                +10.77%
            1J Leistung:
              -71.31%
            Alector Inc Stock (ALEC) Company Profile
Firmenname
                  
                      Alector Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      415-231-5660
                    
                Adresse
                  
                      131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
                    
                Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ALEC
                            
                             
                        Alector Inc 
                           | 
                    1.44 | 148.78M | 100.56M | -119.05M | -231.16M | -1.23 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-22 | Herabstufung | BTIG Research | Buy → Neutral | 
| 2025-10-22 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral | 
| 2025-10-22 | Herabstufung | Mizuho | Outperform → Neutral | 
| 2025-10-22 | Herabstufung | TD Cowen | Buy → Hold | 
| 2025-10-22 | Herabstufung | William Blair | Outperform → Mkt Perform | 
| 2025-07-28 | Hochstufung | Mizuho | Neutral → Outperform | 
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral | 
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold | 
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform | 
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy | 
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight | 
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy | 
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy | 
| 2023-09-25 | Eingeleitet | Goldman | Sell | 
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral | 
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight | 
| 2022-07-07 | Eingeleitet | Mizuho | Buy | 
| 2022-04-13 | Eingeleitet | Goldman | Sell | 
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold | 
| 2021-09-27 | Eingeleitet | William Blair | Outperform | 
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy | 
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy | 
| 2020-04-28 | Eingeleitet | Goldman | Buy | 
| 2020-03-06 | Eingeleitet | Citigroup | Buy | 
| 2020-02-27 | Eingeleitet | Barclays | Overweight | 
| 2020-02-19 | Eingeleitet | Stifel | Buy | 
| 2019-11-21 | Eingeleitet | BTIG Research | Buy | 
| 2019-03-04 | Eingeleitet | Barclays | Overweight | 
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy | 
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight | 
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform | 
                    Alle ansehen
                    
                  
                Alector Inc Aktie (ALEC) Neueste Nachrichten
Evaluating Alector Inc. with trendline analysisPortfolio Risk Report & High Return Trade Opportunity Guides - newser.com
Why Alector Inc. (0Z2) stock is a strong buy callBull Run & Expert-Curated Trade Recommendations - newser.com
Is Alector Inc. stock attractive after correctionCEO Change & AI Driven Price Predictions - newser.com
Full technical analysis of Alector Inc. stockInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Lost Investment in Alector, Inc. (ALEC)? Levi & Korsinsky Launches Securities Fraud Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Why Alector Inc. (0Z2) stock attracts wealthy investorsRisk Management & Technical Pattern Based Buy Signals - newser.com
Is Alector Inc. (0Z2) stock supported by strong fundamentalsPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Will Alector Inc. stock maintain dividend yieldJuly 2025 Breakouts & Weekly High Return Opportunities - newser.com
Why Alector Inc. stock remains undervalued2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
Why Alector Inc. stock remains a top recommendationStock Surge & Free High Accuracy Swing Entry Alerts - newser.com
Is Alector Inc. (0Z2) stock resilient in recession scenariosJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
How to track smart money flows in Alector Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Volatility clustering patterns for Alector Inc.2025 Market Overview & Breakout Confirmation Alerts - newser.com
Is Alector Inc. stock attractive for growth ETFsCEO Change & Short-Term Trading Opportunity Alerts - newser.com
Backtesting results for Alector Inc. trading strategiesTrade Risk Summary & Fast Moving Stock Watchlists - newser.com
Will Alector Inc. stock attract ESG investorsTrade Entry Summary & Scalable Portfolio Growth Ideas - newser.com
ALEC Investor Notice: Levi & Korsinsky Investigates Alector, Inc. for Securities Law Violations - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alector, Inc. (ALEC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
How Alector Inc. (0Z2) stock compares with market leadersPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Why Alector Inc. stock attracts global investorsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Alector, Inc. (ALEC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Alector, Inc. (ALEC) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ALEC | Press Release - Stockhouse
Is Alector Inc. stock a defensive play in 2025Quarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Can Alector Inc. (0Z2) stock hold up in economic slowdown2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab - Insider Monkey
How to build a dashboard for Alector Inc. stock2025 Year in Review & Verified Stock Trade Ideas - newser.com
Is Alector Inc a good long term investmentTrend Following Strategies & High Return Trading Portfolio - earlytimes.in
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):